Dov Gavish - Concepedia

Author

Dov Gavish

Wolfson Medical Center

Also Known As

D GAVISH, D Gavish, D. Gavish, DOV GAVISH, Dov Gavish, Osamah Hussein

108

Publications

3.9K

Citations

H-Index

112

Concepts

All Affiliations

Wolfson Medical Center Tel Aviv University Hadassah Academic College Rockefeller University Sheba Medical Center

About

Dov Gavish is an author at Wolfson Medical Center specializing in medicine, cardiovascular disease, and atherosclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	32	2.6K
2	Public Health	7	7	496
3	Health Sciences	6	6	215
4	Natural Sciences	1	1	156
5	Allergy	1	1	39

Dov Gavish

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations Donald S. Silverberg, Dov Wexler, Miriam Blum, Journal of the American College of Cardiology AnemiaSubcutaneous ErythropoietinHeart FailureCardiovascular DiseaseBlood Transfusion	2000	726
HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels. Gerhard M. Kostner, Dov Gavish, Beate Leopold, Circulation Metabolic SyndromeOxysterolCardiovascular DiseaseBiochemistryMedicine	1989	339
Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment. S Eisenberg, Dov Gavish, Y Oschry, Journal of Clinical Investigation Bezafibrate TreatmentHyperlipidemiaHigh Density LipoproteinsOxidative StressMetabolic Syndrome	1984	295
Plasma Ip(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene. Dov Gavish, Neal Azrolan, J L Breslow Journal of Clinical Investigation Vascular DiseaseGeneticsMolecular BiologyHyperlipidemiaMolecular Genetics	1989	156
Defective metabolism of hypertriglyceridemic low density lipoprotein in cultured human skin fibroblasts. Normalization with bezafibrate therapy. Yosef Kleinman, S Eisenberg, Y Oschry, Journal of Clinical Investigation	1985	123
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab Emil Hagström, Philippe Gabríel Steg, Michael Szarek, Circulation	2022	112
Lipoprotein(a) reduction by N-acetylcysteine Dov Gavish, J L Breslow The Lancet BiochemistryHyperlipidemiaLipoprotein MetabolismMedicineAtherosclerosis	1991	89
Bezafibrate and simvastatin combination therapy for diabetic dyslipidaemia: efficacy and safety Dov Gavish, Eyal Leibovitz, I Shapira, Journal of Internal Medicine	2000	88
Long-Term Thyrotropin-Suppressive Therapy with Levothyroxine Impairs Small and Large Artery Elasticity and Increases Left Ventricular Mass in Patients with Thyroid Carcinoma Marina Shargorodsky, S F Serov, Dov Gavish, Thyroid	2006	85
9-cis β-carotene-rich powder of the alga Dunaliella bardawil increases plasma HDL-cholesterol in fibrate-treated patients Aviv Shaish, Ayelet Harari, Lea Hananshvili, Atherosclerosis Food ChemistryNutritionBiochemistryLipid NutritionMedicine	2006	81

Page 1